# OnCo record cutaneous-t-cell-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "cutaneous-t-cell-lymphoma" ;
  schema:name "Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)"@en ;
  schema:alternateName "CTCL"@en, "Mycosis fungoides"@en, "Sezary syndrome"@en ;
  schema:description "Mycosis fungoides is a lymphoma that lives in the skin, looking like eczema or psoriasis for years before it is diagnosed. It is treated with creams, light and skin-directed radiotherapy for as long as possible, then with antibodies such as mogamulizumab and brentuximab vedotin when it spreads to the blood or lymph nodes."@en ;
  schema:url <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mycosis_fungoides> ;
  schema:citation <https://en.wikipedia.org/wiki/Mycosis_fungoides> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/hypericin-sgx301/> ;
  onco:trials <https://onco.cc/trials/alcanza/>, <https://onco.cc/trials/mavoric/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-who-2022-lymphoid-alaggio-leukemia-2022/>, <https://onco.cc/key-papers/paper-mavoric-mogamulizumab-lancet-oncol-2018/>, <https://onco.cc/key-papers/paper-alcanza-brentuximab-vedotin-lancet-2017/>, <https://onco.cc/key-papers/paper-olsen-mycosis-fungoides-staging-blood-2007/> ;
  onco:pipeline <https://onco.cc/companies/soligenix/>, <https://onco.cc/drugs/mogamulizumab/> ;
  onco:standardOfCare <https://onco.cc/technologies/total-skin-electron-therapy/>, <https://onco.cc/technologies/superficial-radiotherapy/>, <https://onco.cc/drugs/bexarotene/>, <https://onco.cc/drugs/methoxsalen-ecp/>, <https://onco.cc/drugs/bexarotene/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/mogamulizumab/>, <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/vorinostat/>, <https://onco.cc/drugs/romidepsin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/technologies/allogeneic-hsct/> .